These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9799749)

  • 1. K-ras gene mutations in the diagnosis of fine-needle aspirates of pancreatic masses: prospective study using two techniques with different detection limits.
    Mora J; Puig P; Boadas J; Urgell E; Montserrat E; Lerma E; González-Sastre F; Lluís F; Farré A; Capellá G
    Clin Chem; 1998 Nov; 44(11):2243-8. PubMed ID: 9799749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses.
    Villanueva A; Reyes G; Cuatrecasas M; Martínez A; Erill N; Lerma E; Farré A; Lluís F; Capellá G
    Gastroenterology; 1996 May; 110(5):1587-94. PubMed ID: 8613066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras gene mutation in the diagnosis of ultrasound guided fine-needle biopsy of pancreatic masses.
    Zheng M; Liu LX; Zhu AL; Qi SY; Jiang HC; Xiao ZY
    World J Gastroenterol; 2003 Jan; 9(1):188-91. PubMed ID: 12508380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
    Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
    Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer.
    Boadas J; Mora J; Urgell E; Puig P; Roca M; Cussó X; Capellà G; Lluís F; Farré A
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1153-9. PubMed ID: 11711770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A highly sensitive method for K-ras mutation detection is useful in diagnosis of gastrointestinal cancer.
    Puig P; Urgell E; Capellá G; Sancho FJ; Pujol J; Boadas J; Farré A; Lluís F; González-Sastre F; Mora J
    Int J Cancer; 2000 Jan; 85(1):73-7. PubMed ID: 10585586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique.
    Evans DB; Frazier ML; Charnsangavej C; Katz RL; Larry L; Abbruzzese JL
    Ann Surg Oncol; 1996 May; 3(3):241-6. PubMed ID: 8726178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
    J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass.
    Maluf-Filho F; Kumar A; Gerhardt R; Kubrusly M; Sakai P; Hondo F; Matuguma SE; Artifon E; Monteiro da Cunha JE; César Machado MC; Ishioka S; Forero E
    J Clin Gastroenterol; 2007; 41(10):906-10. PubMed ID: 18090159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of pancreatic lesions using fine needle aspiration cytology: detection of K-ras point mutations using solid phase minisequencing.
    Ihalainen J; Taavitsainen M; Salmivaara T; Palotie A
    J Clin Pathol; 1994 Dec; 47(12):1082-4. PubMed ID: 7876379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation.
    Yamaguchi Y; Watanabe H; Yrdiran S; Ohtsubo K; Motoo Y; Okai T; Sawabu N
    Clin Cancer Res; 1999 May; 5(5):1147-53. PubMed ID: 10353750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas.
    Shibata D; Almoguera C; Forrester K; Dunitz J; Martin SE; Cosgrove MM; Perucho M; Arnheim N
    Cancer Res; 1990 Feb; 50(4):1279-83. PubMed ID: 2404591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas].
    Daus H; Trümper L; Bürger B; Jacobs G; Kriener S; von Blohn G; Zeitz M; Pfreundschuh M
    Dtsch Med Wochenschr; 1995 Jun; 120(23):821-5. PubMed ID: 7781522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras mutations and the diagnosis of pancreatic carcinoma.
    Robinson RA
    Am J Clin Pathol; 1996 Mar; 105(3):257-9. PubMed ID: 8602603
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer.
    Salek C; Benesova L; Zavoral M; Nosek V; Kasperova L; Ryska M; Strnad R; Traboulsi E; Minarik M
    World J Gastroenterol; 2007 Jul; 13(27):3714-20. PubMed ID: 17659731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product.
    van Es JM; Polak MM; van den Berg FM; Ramsoekh TB; Craanen ME; Hruban RH; Offerhaus GJ
    J Clin Pathol; 1995 Mar; 48(3):218-22. PubMed ID: 7730480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears.
    Apple SK; Hecht JR; Novak JM; Nieberg RK; Rosenthal DL; Grody WW
    Am J Clin Pathol; 1996 Mar; 105(3):321-6. PubMed ID: 8602613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of K-ras mutations in pancreatic tissue after fine needle aspirates.
    Pabst B; Arps S; Binmoeller K; Thul R; Walsemann G; Fenner C; Klapdor R
    Anticancer Res; 1999; 19(4A):2481-3. PubMed ID: 10470178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-ras mutations and the carcinoembryonic antigen level in fine needle aspirates of the pancreas.
    Pinto MM; Emanuel JR; Chaturvedi V; Costa J
    Acta Cytol; 1997; 41(2):427-34. PubMed ID: 9100777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.